Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03283241
Other study ID # ADD-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2017
Est. completion date October 1, 2020

Study information

Verified date January 2022
Source Addbio AB
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomised, multicentre, double blind, parallel group comparative investigation where subjects will be randomised to receive coated or uncoated implants


Description:

The study will consist of two parts. Part I, is the main study ending when all subjects have reached visit 5. The study will be evaluated and Clinical Study Report (CSR) will be written for this part. Part II, of the study is a post-follow up study starting when the first subject has completed visit 5. There will be a separate CSR written for Study Part II. The study Part I will begin with a baseline visit, visit 1, Informed consent procedure will take place. Provided the subject will give informed consent for both Study Part I and Study Part II the screening procedure starts. Subjects will undergo all screening and baseline assessment procedures including assessments of dental status to determine number of implants needed. Subjects who meet all the inclusion criteria and none of the exclusion criteria will be given a date for implant surgery within three weeks. The required number of implants will be ordered from the Study Distributor. At the implantation day, visit 2, eligibility will be re-checked before the surgery procedures starts. The subjects who still are eligible will enter the treatment and the implantation surgery is conducted. The first follow-up visit after implantation will take place week 2 post-surgery and the last follow-up visit in Study Part I will be at week 12. Any post-surgical complications and adverse events will be collected and recorded in the eCRF. On demand, depending on the outcome of the surgery, additional visits might occur. Study Part II, the Post Follow-up Study, consist of two visits, one at month 12 and another visit at month 24 post-surgery. Post-surgical complications and adverse events from Study Part I will be followed-up if not resolved previously. Safety, survival rate and marginal bone loss will be assessed and outcome recorded in the eCRF. Additional visits might occur depending on the status of the subjects.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date October 1, 2020
Est. primary completion date July 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male or female subjects aged >18 years - Subjects should be willing to take part, able to understand the information given to them, and give written consent - Subject diagnosed with partial edentulism and who needs at least one dental implant in the posterior upper jaw i.e. premolars to first molar. The same subject may also need implants in the posterior mandible (premolars to first molar region) Exclusion Criteria: - Suspected to be immunocompromised or are taking immunosuppressant - Current participation in another clinical investigation or participation within the last 6 months - Known sensitivity/allergies to any of the test materials or any of their ingredients, such as bisphosphonate, titanium or human fibrinogen - Significant current or past medical history of hepatic, renal, cardiac, pulmonary, digestive, haematological, neurological, or psychiatric disease, hypercalcaemia, previous or ongoing malignancy in the head and neck region or uncontrolled diabetes type I which in the opinion of the Investigator, would compromise the safety of the subject or affect the outcome of the investigation - Pregnant and lactating females or those actively seeking to become pregnant in the next 3 months - Previous (last 5 years) or on-going Bisphosphonate or Denosumab treatment - Significant marginal bone loss prior to implant insertion requiring bone grafting or bone graft substitute - Subject with extraction(s) performed in the position of implant placement within the last 2 months - Subject with need of >6 implants or a full bridge - The final prosthetic construction in need of support from neighbouring teeth - Known drug or alcohol abuse - Subjects only needed implant(s) in the posterior mandible region

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Zolidd One ExHex
Subject will be treated/implanted at visit 2, one of the implants will be chosen as the "index implant"and will be followed together with other implants (maximum 6 implant per subject) at week 8,12 and month 12 and 24.
One ExHex
Subject will be treated/implanted at visit 2, one of the implants will be chosen as the "index implant"and will be followed together with other implants (maximum 6 implant per subject) at week 8,12 and month 12 and 24.

Locations

Country Name City State
Sweden Dingletandläkarna Dingle
Sweden Praktikertjänst AB Holmgatans Tandläkarmottagning Falun
Sweden Käk-kirurgiska Kliniken, Näl Trollhättan

Sponsors (1)

Lead Sponsor Collaborator
Addbio AB

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Stability at 12 Weeks Minus Value at Baseline (Day 1) Comparing Coated and Uncoated Implants Change in Stability From Day 1(Implantation to 12 Weeks After Implantation of the "Index Implant" Comparing Coated and Uncoated Implants The primary objective is to compare the mean change in stability at 12 weeks minus value at baseline (day 1)after surgery of the "index implant" between coated and uncoated implants.
An ISQ (Implant Stability Quotient) probe is used to measure the stability of the implant ISQ (Implant Stability Quotient) scale is 1-100
1 No stability 100 stability The aim is to get as close to a 100 as possible
12 weeks
Secondary To Compare Absolute ISQ (Implant Stability Quotient) Highest Values Between Coated and Uncoated Implants for the "Index Implant" at Week 8 and Week 12 To compare absolute ISQ (Implant Stability Quotient) highest values between coated and uncoated "index implants" at week 8 and week 12 after implantation An ISQ (Implant Stability Quotient) probe is used ISQ scale is 1-100
1 No stability 100 stability Aim its to get close to 100
week 8 and week 12
Secondary Incidence of Post-surgery Complications and Adverse Events To compare safety as assessed by complications post-surgery and any other adverse event up to week 12 between all coated and all uncoated implants Day1 to week 12
Secondary Change in ISQ (Implant Stability Quotient) Highest Value for the "Index Implant" To compare change in stability from day 1 to week 8 between the coated and the uncoated "index implants" An ISQ (Implant Stability Quotient) probe is used to measure the stability of the implant ISQ (Implant Stability Quotient) scale is 1-100
1 No stability 100 stability The aim is to get as close to a 100 as possible
Day 1 to week 8
Secondary Change in ISQ Highest Value for All Other Implants To compare change in stability from day 1 to week 8 and 12 between all other coated and all other uncoated implants An ISQ (Implant Stability Quotient) probe is used ISQ scale is 1-100
1 No stability 100 stability
week 8 and week 12
Secondary Absolute ISQ (Implant Stability Quotient) Highest Value for All Other Implants To compare absolute ISQ (Implant Stability Quotient) highest value at week 8 and 12 between all other coated and all other uncoated implants An ISQ (Implant Stability Quotient) probe is used ISQ scale is 1-100
1 No stability 100 stability
Week 8 and 12
Secondary Change in Marginal Bone Height for All Other Implants To compare change in marginal bone height between all coated and all uncoated implants from at week 8 and 12 The marginal bone height is measured by x-ray and measuring the distance between the implant and bone in mm (millimeter) week 8 and 12
Secondary Post-surgical Complications and Other Adverse Events (AEs) for All Implants To compare safety as assessed by complications post-surgery and other adverse events up to month 24 post-implantation visit between all coated and all uncoated implants month 24
Secondary Survival Rate for All Implants To compare survival rate of implants up to 24 months between all coated and all uncoated implants 24 months
Secondary Change in Marginal Bone Height for All Implants To compare change in marginal bone height from day 1 to month 12 and 24 between all coated and all uncoated implants The marginal bone height is measured by x-ray and measuring the distance between the implant and bone in mm (millimeter) Day 1, month 12 and 24
Secondary Occurrence of Signs Associated With Peri-implantitis for All Implants To compare peri-implantitis frequency at 12 and 24 months between all coated and all uncoated implants Ocular assessment of redness and swelling this is an overall judgement of peri-implantitis Month 12 and 24
See also
  Status Clinical Trial Phase
Completed NCT00713206 - Prospective Study of NanoTite Implants Placed Into Fresh Sinus-Lift Augmentation Sites (VSSL) N/A
Completed NCT00728884 - Study of Certain Prevail Implants Used to Treat All Types of Edentulism in the Maxilla and Mandible
Completed NCT01529775 - Randomized Study of Osseotite Certain Tapered Prevails vs. Osseotite Certain Tapered N/A
Completed NCT03934853 - Study to Confirm Accuracy and Safety of the Inliant Surgical Navigation System N/A
Completed NCT03769376 - Histologic Comparison of Healing After Tooth Extraction With Ridge Preservation Using Two Different Xenografts N/A
Completed NCT01953991 - OHQoL With Removable Partial Dentures; a Pilot Study N/A
Completed NCT02387970 - Immediate or Delayed Provisionalization in Posterior Healed Sites N/A
Completed NCT02158377 - TM vs TSV Implants Loaded Early vs Conventional in Anterior and Posterior Areas N/A
Completed NCT01324778 - Multi Centre Study Comparing OsseoSpeed TX With OsseoSpeed N/A
Terminated NCT02188212 - Nobel Procera Crown Shaded Zirconia and NobelProceraTM Full Contour Crown IPS e.Max CAD N/A
Completed NCT00728754 - A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases. N/A
Completed NCT00728962 - A Study of Osseotite Certain Prevail Implants Used to Support Short Fixed Bridges With Immediate Occlusal Loading.
Active, not recruiting NCT03558347 - CF41102 5-year Clinical Evaluation of Conelog® Implant With 7 mm Length N/A
Withdrawn NCT02590861 - Improving Oral Health Function With Implant Supported Partial Dentures N/A
Completed NCT02507661 - Effect of Alveolar Ridge Preservation on Implant Esthetic Outcomes Phase 4
Completed NCT02404649 - Comparing Conventional Dental Implants and Trabecular Metalâ„¢ Dental Implants After Sinus Floor Elevation N/A
Completed NCT02703168 - Long-term Performance of SLActive Implants After Immediate or Early Loading N/A
Completed NCT01529814 - Assessment of Integration Success of an Implant System With a Novel Abutment Attachment Design in Early Loaded Cases N/A
Completed NCT00782171 - Evaluation of Immediate Versus Delayed Loading of Dental Implants With a Modified Surface Phase 4
Enrolling by invitation NCT04140006 - Efficacy of Antiresorptive and Bone Forming Material on Dental Implants Phase 1/Phase 2